Related Experiment Videos
Activation of DNA metabolism in T-cells by bestatin
Biochemical Pharmacology
|October 15, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Synthesis and antitumor activity of 4'-O-acylanthracyclines.
The Journal of antibiotics·1992
Ascorbic acid and adriamycin toxicity.
The American journal of clinical nutrition·1991
Synthesis of 3'-deoxy-3'-fluorokanamycin A and 3',4'-dideoxy-3'-fluorokanamycin A.
Carbohydrate research·1991
Post-ischaemic treatment with the prostacycline analogue TTC-909 reduces ischaemic brain injury.
Acta neurochirurgica. Supplementum·1990
Local cerebral blood flow and glucose metabolism in hydrostatic brain oedema.
Acta neurochirurgica. Supplementum·1990
Combination pharmacotherapy for MASH: Potential synergistic approaches.
Biochemical pharmacology·2026
Non-invasive evaluation of early liver fibrosis process by targeting αvβ6 integrin PET imaging.
Biochemical pharmacology·2026
Bacterial protein post-translational modifications: a dynamic regulatory layer of antibiotic resistance.
Biochemical pharmacology·2026
In vivo CAR‑T cell therapy: mechanisms, clinical advances and optimization strategies.
Biochemical pharmacology·2026
HER2-Targeted AIE Nanotheranostics Overcome SHR-A1811 Resistance via Immunogenic Pyroptosis and Tumor-Associated Macrophage Reprogramming in Breast Cancer.
Small (Weinheim an der Bergstrasse, Germany)·2026
Systemic administration of the PRMT5 inhibitor GSK3326595 does not induce overt cardiotoxicity in the murine heart.
Journal of molecular and cellular cardiology plus·2026
Promotion or suppression? Does internet use by the Chinese public affect physician trust?
Frontiers in public health·2026
The Phosphate-Specific Transport System Gene pstA1 Contributes to Rifampin Tolerance in Mycobacterium tuberculosis.
The Journal of infectious diseases·2026
Could thiamine supplementation delay the progression of retinal dystrophy in Rogers syndrome?
Ophthalmic genetics·2026
Treat-to-target: LLDAS, DORIS remission, and flare prevention strategies.
Rheumatology (Oxford, England)·2026